75.08 0.00 (0.00%)
After hours: 4:15PM EDT
|Bid||73.06 x 300|
|Ask||77.49 x 300|
|Day's range||75.07 - 76.79|
|52-week range||48.56 - 78.28|
|PE ratio (TTM)||81.61|
|Earnings date||23 May 2018 - 29 May 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||72.18|
Veeva Systems and Columbus 2020 today announced that Veeva is expanding its presence in Columbus, Ohio to support the company’s future growth. Veeva plans to increase to 130 employees in three years across its engineering, IT, services, and finance organizations in the region.
Veeva Systems , today announced that Ora, Inc., a leading ophthalmic CRO, adopted the Veeva Vault Clinical Suite to unify its clinical systems and processes. Ora is bringing together CTMS, eTMF, and study start-up applications on one platform to improve operational efficiency and visibility throughout its clinical trials.
Software, chemical and some select cyclical shares stampeded higher, helping lead a broad rebound on Monday.
The bulls are trying to find bargains following investor fear over a potential trade war.
Here are some things going on today in your world of tech: It's not snowing in Barcelona like yesterday, but it's still cold and rainy as the Mobile World Congress, the biggest telecom and smartphone trade show, continues. Apple (AAPL) is not at the show, at least, not officially, but it's always a topic of discussion at Mobile World. Canaccord Genuity's Mike Walkley writes that his meetings at the show suggest sales of the iPhone X will remain under pressure the first half of this year.
Veeva Systems (VEEV) continues to witness year-over-year growth on earnings and revenues backed by the company's consistent efforts in product innovation and launches via R&D.
Veeva Systems today announced that Dr. William H. Carson, president and CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. , and Jeffrey D. Marrazzo, CEO of Spark Therapeutics, will be featured keynote speakers at the 2018 Veeva Commercial & Medical Summit.
Life sciences cloud computing application vendor Veeva Systems (VEEV), Tuesday afternoon reported Q4 revenue and profit that topped analysts’ expectations, and beat with its forecast, sending its shares higher in late trading. In an interview following the reported, chief financial officer Tim Cabral and chief marketing officer Nitsa Zuppas told Barron’s the company is making progress, though still early, in expanding beyond life sciences.
The Pleasanton, California-based company said it had net income of 22 cents per share. Earnings, adjusted for one-time gains and costs, came to 23 cents per share. The results beat Wall Street expectations. ...
Veeva reported adjusted income of 23 cents per share on sales of $184.9 million for its fourth quarter.
Veeva Systems Inc. , a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal fourth quarter and full year ended January 31, 2018.
Veeva Systems Inc. a leading industry cloud provider for life sciences, today announced participation in the following investor conferences:
If there were a healthcare Olympics, this company's revolutionary software solution would win it the gold.
Veeva Systems Inc. , a leading industry cloud provider for life sciences, will announce financial results for its fiscal fourth quarter and full fiscal year which ended January 31, 2018 after market close on February 27, 2018.
Veeva Systems today announced that specialty pharmaceutical company EVER Pharma adopted Veeva OpenData and Veeva CRM to empower its growing team in Poland with the accurate customer data necessary to drive smarter, tailored engagement with healthcare professionals .
Veeva Systems (VEEV) rides on growing demand for cloud-based and vault applications. However, the company faces cutthroat competition in the niche space.